Walgreens’s undertaking to provide accessible health care while still making a profit isn’t unrealistic. “I think they’re probably right,” says Elizabeth McGlynn, associate director at policy think tank Rand Health, about Walgreens’s win-win. “If there is no reform, retail clinics offer convenience and lower pricing. And they may well be stimulated by policy changes that put more of a share of costs on consumers as well.”
Walgreens knows this. The business part may be first and foremost for the company, but Rosenbluth’s mission is to do good while doing good busi-ness, as he likes to say. “We’ll do this part,” he says. Now it’s the government’s turn.
